Juno Therapeutics, Inc.·4

Jun 19, 4:32 PM ET

Juno Therapeutics, Inc. 4

4 · Juno Therapeutics, Inc. · Filed Jun 19, 2017

Insider Transaction Report

Form 4
Period: 2017-06-16
Barron Hal
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2017-06-16+12,00012,000 total
    Exercise: $23.29Exp: 2027-06-15Common Stock (12,000 underlying)
Footnotes (1)
  • [F1]100% of the shares subject to the option become vested and exercisable on the earlier of (i) the date of the 2018 Annual Meeting of Stockholders and (ii) the first anniversary of the grant date, in either event, subject to the director continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan) through such date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION